» Articles » PMID: 37308974

The LncRNA HOTAIR: a Pleiotropic Regulator of Epithelial Cell Plasticity

Overview
Publisher Biomed Central
Specialty Oncology
Date 2023 Jun 12
PMID 37308974
Authors
Affiliations
Soon will be listed here.
Abstract

The epithelial-to-mesenchymal transition (EMT) is a trans-differentiation process that endows epithelial cells with mesenchymal properties, including motility and invasion capacity; therefore, its aberrant reactivation in cancerous cells represents a critical step to gain a metastatic phenotype. The EMT is a dynamic program of cell plasticity; many partial EMT states can be, indeed, encountered and the full inverse mesenchymal-to-epithelial transition (MET) appears fundamental to colonize distant secondary sites. The EMT/MET dynamics is granted by a fine modulation of gene expression in response to intrinsic and extrinsic signals. In this complex scenario, long non-coding RNAs (lncRNAs) emerged as critical players. This review specifically focuses on the lncRNA HOTAIR, as a master regulator of epithelial cell plasticity and EMT in tumors. Molecular mechanisms controlling its expression in differentiated as well as trans-differentiated epithelial cells are highlighted here. Moreover, current knowledge about HOTAIR pleiotropic functions in regulation of both gene expression and protein activities are described. Furthermore, the relevance of the specific HOTAIR targeting and the current challenges of exploiting this lncRNA for therapeutic approaches to counteract the EMT are discussed.

Citing Articles

Copper in the colorectal cancer microenvironment: pioneering a new era of cuproptosis-based therapy.

Feng Q, Sun Y, Yang Z, Wang Z, Chen Z, Liu F Front Oncol. 2025; 14():1522919.

PMID: 39850821 PMC: 11754209. DOI: 10.3389/fonc.2024.1522919.


The roles and mechanisms of coding and noncoding RNA variations in cancer.

Kim S, Na M, Yoon S, Shin E, Ha J, Jeon S Exp Mol Med. 2024; 56(9):1909-1920.

PMID: 39218979 PMC: 11447202. DOI: 10.1038/s12276-024-01307-x.


Noncoding RNAs in chronic obstructive pulmonary disease: From pathogenesis to therapeutic targets.

Ren B, Su H, Bao C, Xu H, Xiao Y Noncoding RNA Res. 2024; 9(4):1111-1119.

PMID: 39022682 PMC: 11254503. DOI: 10.1016/j.ncrna.2024.06.005.


The role of HOTAIR in the modulation of resistance to anticancer therapy.

Cantile M, Belli V, Scognamiglio G, Martorana A, De Pietro G, Tracey M Front Mol Biosci. 2024; 11:1414651.

PMID: 38887279 PMC: 11181001. DOI: 10.3389/fmolb.2024.1414651.


Genomic characterization of cervical lymph node metastases in papillary thyroid carcinoma following the Chornobyl accident.

Morton L, Lee O, Karyadi D, Bogdanova T, Stewart C, Hartley S Nat Commun. 2024; 15(1):5053.

PMID: 38871684 PMC: 11176192. DOI: 10.1038/s41467-024-49292-z.


References
1.
Cicchini C, Laudadio I, Citarella F, Corazzari M, Steindler C, Conigliaro A . TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling. Exp Cell Res. 2007; 314(1):143-52. DOI: 10.1016/j.yexcr.2007.09.005. View

2.
Ma F, Xie Y, Lei Y, Kuang Z, Liu X . The microRNA-130a-5p/RUNX2/STK32A network modulates tumor invasive and metastatic potential in non-small cell lung cancer. BMC Cancer. 2020; 20(1):580. PMC: 7310151. DOI: 10.1186/s12885-020-07056-0. View

3.
Parviz F, Matullo C, Garrison W, Savatski L, Adamson J, Ning G . Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet. 2003; 34(3):292-6. DOI: 10.1038/ng1175. View

4.
Garrison W, Battle M, Yang C, Kaestner K, Sladek F, Duncan S . Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon. Gastroenterology. 2006; 130(4):1207-20. PMC: 3581272. DOI: 10.1053/j.gastro.2006.01.003. View

5.
Garibaldi F, Cicchini C, Conigliaro A, Santangelo L, Cozzolino A, Grassi G . An epistatic mini-circuitry between the transcription factors Snail and HNF4α controls liver stem cell and hepatocyte features exhorting opposite regulation on stemness-inhibiting microRNAs. Cell Death Differ. 2011; 19(6):937-46. PMC: 3354047. DOI: 10.1038/cdd.2011.175. View